Stock Research: LifeMD

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

LifeMD

NasdaqGM:LFMD US53216B1044
65
  • Value
    1
  • Growth
    92
  • Safety
    Safety
    75
  • Combined
    65
  • Sentiment
    66
  • 360° View
    360° View
    65
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

LifeMD, Inc. is a direct-to-patient telehealth company that provides comprehensive virtual and in-home healthcare. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company operates through two segments: Telehealth and WorkSimpli. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. WorkSimpli is a provider of workplace and document services for consumers, gig workers, and small businesses. It operates brands including: PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild, a provider of digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 65 (better than 65% compared with alternatives), overall professional sentiment and financial characteristics for the stock LifeMD are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for LifeMD. The consolidated Value Rank has an attractive rank of 75, which means that the share price of LifeMD is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 75% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 92, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 66. But the company’s financing is risky with a Safety rank of 1. This means 99% of comparable companies have a safer financing structure than LifeMD. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
75 76 70 93
Growth
92 87 95 83
Safety
Safety
1 6 15 1
Sentiment
66 70 78 99
360° View
360° View
65 75 82 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
75 76 72 94
Opinions Change
50 50 50 96
Pro Holdings
n/a 39 51 72
Market Pulse
51 75 73 50
Sentiment
66 70 78 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
75 76 70 93
Growth
92 87 95 83
Safety Safety
1 6 15 1
Combined
65 63 80 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
20 4 35 35
Price vs. Earnings (P/E)
84 59 51 96
Price vs. Book (P/B)
100 100 97 96
Dividend Yield
1 1 1 1
Value
75 76 70 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
69 85 86 81
Profit Growth
83 27 72 49
Capital Growth
84 87 45 95
Stock Returns
86 71 99 29
Growth
92 87 95 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
1 13 62 52
Refinancing
6 8 13 3
Liquidity
18 22 13 8
Safety Safety
1 6 15 1

Similar Stocks

Discover high‑ranked alternatives to LifeMD and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Tyson Foods

NYSE:TSN
Country: USA
Industry: Packaged Foods & Meats
Size: X-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.